Safety of etanercept therapy in rheumatoid patients undergoing surgery: Preliminary report

Clinical Rheumatology

Volumn 26, Issue 9, 2007, Pages 1513-1515

  Corrao, Salvatore ^a   Pistone, Giovanni ^b   Arnone, Sabrina ^b   Calvo, Luigi ^a   Scaglione, Rosario ^a   Licata, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b National Relevance Hospital Trust Civico e Benfratelli G di Cristina M Ascoli   (Italy)

Author keywords

Anti rheumatic agents; Etanercept; Patient satisfaction; Rheumatoid arthritis; Surgery

Indexed keywords

ANTIBIOTIC AGENT; ETANERCEPT;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HUMAN; INFECTION; MALE; PATIENT SATISFACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WOUND HEALING;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECEPTORS, TUMOR NECROSIS FACTOR; SURGICAL PROCEDURES, ELECTIVE; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 34447134805     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0534-0     Document Type: Article

References (10)

1. Puppo F, Murdaca G, Ghio M, Indiveri F (2005) Emerging biologic drugs for the treatment of rheumatoid arthritis. Autoimmun Rev 4(8):537-541
2. Fleischmann RM, Iqbal I, Stern RL (2004) Considerations with the use of biological therapy in the treatment of rheumatoid arthritis. Expert Opin Drug Saf 3(5):391-403
3. Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW (2002) Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 103:13-21
4. Farrow SJ, Kingsley GH, Scott DL (2005) Interventions for foot disease in rheumatoid arthritis: A systematic review. Arthritis Rheum 53(4):593-602
5. Szpalski M, Gunzburg R (2002) What are the advances for surgical therapy of inflammatory diseases of the spine? Best Pract Res Clin Rheumatol 16(1):141-154
6. Munjal S, Phillips MJ, Krackow KA (2001) Revision total knee arthroplasty: Planning, controversies, and management-infection. Instr Course Lect 50:367-377
7. Schrieber S, Campieri M, Colombel JF, van Deventer SJH, Feagan B, Fedorak R et al (2001) Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003. Int J Colorectal Dis 16:1-11
8. Jain A, Maini R, Nanchahal J (2004) Rheumatoid arthritis: The need for more data disease. Ann Rheum Dis 63:602-603
9. Bibbo C, Goldberg JW (2004) Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 25(5):331-335
10. Montastruc JL, Bagheri H, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M (2005) Nouvelles méthodes d'étude du risque médicamenteux: L'experience du Centre Midi-Pyrénées de Pharmacovigilance. [New methods for studying drug associated risk: Experience of the Toulouse Regional Pharmacovigilance Center]. Bull Acad Natl Med 189(3):493-502